You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zytiga

Showing 26 - 50 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Prostate Cancer Trial in Boston (Cabozantinib, Abiraterone)

Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 5, 2021

Prostate Cancer Trial in Durham, Houston (Abiraterone acetate, Androgen deprivation, Radiation Therapy)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Abiraterone acetate
  • +3 more
  • Durham, North Carolina
  • +2 more
Oct 27, 2021

Prostate Cancer Trial in United States (Zytiga® (Abiraterone Acetate), SoluMatrix™ (Abiraterone Acetate))

Completed
Has Results
  • Prostate Cancer
  • Zytiga® (Abiraterone Acetate)
  • SoluMatrix™ (Abiraterone Acetate)
  • Laguna Hills, California
  • +16 more
Nov 19, 2021

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Chengdu, China
  • +7 more
Aug 5, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Abiraterone Acetate, Sodium Selenite, Prednisone)

Withdrawn
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • (no location specified)
Aug 5, 2021

Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Omaha, Nebraska
  • +1 more
Aug 26, 2021

Prostate Cancer Trial in Gyeonggi-do (BR9004, BR9004-1)

Completed
  • Prostate Cancer
  • Gyeonggi-do, Seongnam-si, Korea, Republic of
    CHA Bundang Medical Center, CHA University
Jul 20, 2021

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • La Jolla, California
  • +3 more
Sep 1, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)

Unknown status
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
May 14, 2021

Prostate Cancer Trial in Nijmegen (abiraterone)

Completed
  • Prostate Cancer
  • Nijmegen, Netherlands
    Radboud UMC
Dec 4, 2020

Salivary Glands Tumors Trial in Milan (Abiraterone acetate)

Completed
  • Salivary Glands Tumors
  • Abiraterone acetate
  • Milan, Lombardy, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Mar 1, 2021

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Prostate Cancer Trial in Boston (Abiraterone, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 8, 2021

Prostate Cancer, Castrate Sensitive Prostate Cancer, Oligometastatic Disease Trial in Ann Arbor (drug, radiation, biological)

Recruiting
  • Prostate Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jun 1, 2021

Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • San Diego, California
  • +25 more
Jan 10, 2023

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022